Skip to main content

Table 4 Comparison of EQ-5D and SF-6D in patient subgroups where there were expected improvements in health status

From: Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain

Patient subgroup

EQ-5D change from baseline

SF-6D change from baseline

Patients who completed the trial and had no adverse events

0.252

0.094

Patients who completed the trial and had >30% pain relief

0.286

0.113

Patients with at least one AE

0.157

0.049

Patients with an AE that lead to withdrawal

0.073

0.005

Patients who discontinued therapy due to lack of efficacy

0.032

0.006